ArticleTheranostics2022

Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1.

Chan-Hyeong Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.